Glucosylsphingosine (lyso-Gb1) as a Biomarker for Monitoring Treated and Untreated Children with Gaucher Disease

The role of glucosylsphingosine (lyso-Gb1), a downstream metabolic product of glucosylceramide, for monitoring treated and untreated children with Gaucher disease (GD) has not yet been studied. We reviewed the clinical charts of 81 children (<18 years), 35 with mild type 1 GD (GD1), 34 with sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurvitz, Noa, Dinur, Tama, Becker-Cohen, Michal, Cozma, Claudia, Hovakimyan, Marina, Oppermann, Sebastian, Demuth, Laura, Rolfs, Arndt, Abramov, Aya, Zimran, Ari, Revel-Vilk, Shoshana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627663/
https://www.ncbi.nlm.nih.gov/pubmed/31234327
http://dx.doi.org/10.3390/ijms20123033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627663/
https://www.ncbi.nlm.nih.gov/pubmed/31234327
http://dx.doi.org/10.3390/ijms20123033

Ejemplares similares